神州细胞上半年亏损 2020年上市2募资共17.7亿

Core Insights - The company Shenzhou Cell (688520.SH) reported a significant decline in its financial performance for the first half of 2025, with a revenue of 972 million yuan, representing a year-on-year decrease of 25.50% [1][3]. - The net profit attributable to shareholders was -33.77 million yuan, indicating a substantial loss compared to a profit of 125.71 million yuan in the same period last year, marking a decrease of 126.87% [1][3]. - The net cash flow from operating activities was -206.12 million yuan, a drastic decline of 257.03% compared to the previous year [1][3]. Financial Performance Summary - Revenue: 972 million yuan, down 25.50% from 1.30 billion yuan [3]. - Total profit: -33.86 million yuan, down 126.86% from 126.07 million yuan [3]. - Net profit attributable to shareholders: -33.77 million yuan, down 126.87% from 125.71 million yuan [3]. - Net profit excluding non-recurring items: -36.11 million yuan, down 110.61% from 340.26 million yuan [3]. - Net cash flow from operating activities: -206.12 million yuan, down 257.03% from 131.27 million yuan [3]. Company Background - Shenzhou Cell was listed on the Shanghai Stock Exchange on June 22, 2020, with an initial share issuance of 50 million shares at a price of 25.64 yuan per share [1][4]. - The total amount raised from the initial public offering was 1.28 billion yuan, with a net amount of 1.20 billion yuan after expenses [4][6]. - The company also conducted a private placement of A-shares in 2021, raising approximately 483.3 million yuan [4][5].